Search

everythinglearnresearchcommunity

for

Search:↓

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

STEAP3 protein might help treat hair loss, but more testing is needed.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Human tissue kallikreins help regulate skin barrier functions and affect skin health.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

A protein called MPZL3 in mitochondria slows down hair growth and could be a target for treating hair growth disorders.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Transglutaminase-3 is often reduced in esophageal cancer.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.